Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
BioLife Solutions (BLFS) Stock Price & Analysis
363 Followers
BLFS Stock Chart & Stats
Day’s Range$16.1 - $17.12
52-Week Range― - ―
Previous Close$17.19
Volume400.85K
Average Volume (3M)N/A
Market Cap
$771.01M
Enterprise Value$762.00M
Total Cash (Recent Filing)$51.70M
Total Debt (Recent Filing)$42.69M
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.56
Enterprise Value/Gross Profit11.29
Enterprise Value/Ebitda-13.80
Forecast
1Y Price Target
$23.60Price Target Upside39.98% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
BioLife Solutions News
Ownership Overview
46.96% Insiders
24.21% Mutual Funds
17.31% Other Institutional Investors
11.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLFS FAQ
What was BioLife Solutions’s price range in the past 12 months?
Currently, no data Available
What is BioLife Solutions’s market cap?
Currently, no data Available
When is BioLife Solutions’s upcoming earnings report date?
BioLife Solutions’s upcoming earnings report date is May 09, 2024 which is in 13 days.
How were BioLife Solutions’s earnings last quarter?
BioLife Solutions released its earnings results on Feb 29, 2024. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.342 by $0.042.
Is BioLife Solutions overvalued?
According to Wall Street analysts BioLife Solutions’s price is currently Undervalued.
Does BioLife Solutions pay dividends?
BioLife Solutions does not currently pay dividends.
What is BioLife Solutions’s EPS estimate?
BioLife Solutions’s EPS estimate is -$0.32.
How many shares outstanding does BioLife Solutions have?
Currently, no data Available
What happened to BioLife Solutions’s price movement after its last earnings report?
BioLife Solutions reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.342. Following the earnings report the stock price went up 6.331%.
Which hedge fund is a major shareholder of BioLife Solutions?
Among the largest hedge funds holding BioLife Solutions’s share is Royce & Associates LLC. It holds BioLife Solutions’s shares valued at 14M.
---
BioLife Solutions Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.60 (39.98% Upside)
$23.60 (39.98% Upside)
Blogger Sentiment
Bullish
BLFS Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 628.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $189.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.16%
12-Months-Change
Fundamentals
Return on Equity
-18.93%
Trailing 12-Months
Asset Growth
-8.33%
Trailing 12-Months
Company Description
BioLife Solutions
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.
---
BLFS Earnings Call
Q4 2024
0:00 / 0:00
---
BLFS Revenue Breakdown
45.91% Cell processing
36.05% Freezer and thaw
18.04% Biostorage services
---
BLFS Stock 12 Months Forecast
Average Price Target
$23.60
▲(39.98% Upside)
Technical Analysis
Bioline RX Ltd Sponsored ADR
―
Brainstorm Cell Therapeutics
―
Crispr Therapeutics AG
―
Editas Medicine
―
Best Analysts Covering BLFS
1 Year
1 Year Success Rate
6/10 ratings generated profit
1 Year Average Return
+42.81%
reiterated a buy rating 8 days ago
Copying Thomas Flaten's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +42.81% per trade.
---